. Understanding the relationship between morphological phenotype and the underlying molecular alterations effecting chromatin structure is important but infrequently studied.
In normal cells an equilibrium of histone acetyltransferases (HATs) and histone deacetylases (HDAC) regulate the acetylation and deacetylation of specific internal lysine residues located on the exposed amino terminals of histone proteins [11] [12] . One strategy for analysing the precise effects of histone acetylation is to block the activities of these acetylating or deacetylating enzymes by specific inhibitors. Trichostatin A (TSA) is a potent, non-competitive inhibitor that is highly specific for HDACs. TSA has been found to exhibit anti-proliferative properties at nanomolar concentrations in transformed cells by inducing cell cycle arrest, differentiation and apoptosis [13] [14] [15] . TSA treatment has been associated with global hyperacetylation that may lead to the activation of transcription of a selection of genes that inhibit tumour growth [16] [17] [18] [19] . Recent studies have shown specific gene expression changes in response to TSA treatment that subsequently impact cell cycle and apoptotic pathways [20] [21] [22] . [23] [24] .
However, in this study we have focused on measuring the impact of TSA treatment on the global acetylation status of the cell and the morphological phenotype of the nucleus in terms of chromatin condensation and distribution using quantitative methods. This study has focused exclusively on acetylation of histone 3 at the lysine 9 residue due to the identification of H3K9 acetylation as a primary step in the sequence of acetylation at histone 3, and its potential role as an epigenetic switch in the re-expression of genes, in an environment of repressive heterochromatin

Materials and methods
Cell culture and TSA treatment
PNT1A prostate cell line was purchased from European Collection of Cell Culture. LNCaP and DU145 cells were purchased from DSMZ (Braunschweig, Germany). All cell lines were grown and maintained in RPMI 1640 nutrient medium (Sigma, Dorset, UK) supplemented with foetal calf serum (Labtech International, East Sussex, UK), 4 mM/l L-glutamine (Sigma) 0.06 mg/ml benzylpenicillin and 0.1 mg/ml streptomycin (Sigma). TSA (Sigma) was administered at 12 ng/ml and 100 ng/ml concentrations for 24 hrs.
Flow cytometric cell cycle analysis
Adherent cells were harvested by trypsinization and fixed in methanol.
Cells were stained with 500 l of 30 g/ml propidium iodide (PI) (Sigma) containing 100 g/ml RNase (Sigma) and 5 g/ml triton (Sigma) (Fig. 4B) . (Fig. 5B) . Measurements for a selection of those texture features, which were significantly altered in response to TSA treatment in PNT1A cells, were plotted using mean and 95% confidence limits in order to identify specific changes in chromatin organization (Fig. 5C) . In response to TSA treatment PNT1A chromatin was found to be dramatically decondensed, as illustrated by the low values of mean density texture feature following 100 ng/ml TSA treatment and the significant increase in the number of low-density objects following both low and high doses of TSA. Significant distributional changes were also induced by TSA and these alterations were also identified in response to low doses. Combined quantitative information from several distributional features showed that following low doses of TSA a more uniform chromatin phenotype was evident in PNT1A G0/G1 nuclei (energy) and areas of high-density chromatin were predominantly localized to the nuclear periphery (high average distance), whereas at high doses chromatin was less uniform (energy) and regions of high density (high average distance) appeared most often within the nuclear interior (Fig. 5C) 
Fig. 3 TSA-induced hyperacetylation results in the disruption of chromatin condensation and distribution. (A) Haematoxylin stained PNT1A and LNCaP cells were visually assessed for chromatin changes and red arrows highlight areas of heterochromatin where chromatin appears to disperse following TSA treatment. In general chromatin was more granular in both cell lines following low doses of TSA treatment whereas after high doses of TSA cell cycle perturbations were evident with the increased presence of apoptotic bodies in PNT1A cells and a large number of mitotic bodies in LNCaP populations. (B) High-resolution digital texture analysis of haematoxylin stained cells allowed the quantitative analysis of chromatin changes through the assessment of 65 chromatin texture features for each cell nucleus. Graphs were plotted representing 95% confidence intervals for a subset of chromatin texture features significantly altered by TSA treatment including; mean density, sum density, low-density objects, highdensity objects and energy.
Selective analysis of chromatin organization in flow sorted G 1 cells following TSA induced hyperacetylation
It was clear from the above studies that the analysis of induced chromatin rearrangement must be carried out on cell cycle specific populations, otherwise results may be confounded by the variable cell cycle response to TSA. In a new approach to measuring chromatin textural changes, quantitative fluorescence texture analysis was performed on cells treated with TSA and subsequently flow cytometrically sorted G1 cell populations stained with PI for the assessment of chromatin and simultaneously with anti-AcH3K9/FITC in order to detect the spatial characteristics of TSA-induced global hyperacetylation in G1 cells (Fig. 5A). This analysis was performed in order to study the direct impact of low and high doses of TSA treatment on the global density and distribution of nuclear chromatin in PNT1A, LNCaP and DU145 cells, in the absence of confounding chromatin remodelling events that occur between cell cycle phases. As before, 65 texture features were measured in order to quantitatively evaluate visual and subvisual changes in chromatin organization and H3K9 distribution with the nucleus. As expected, an increase in H3K9 acetylation was observed in G1 cells from all three cell lines in response to TSA treatment. In addition, TSA at both low and high doses was also found to induce significant differences in the distribution of H3K9 acetylation throughout the nuclei of PNT1A, LNCaP and DU145 cells, with low
Fig. 4 Global H3K9 acetylation patterns are altered across the cell cycle. Following TSA treatment with 12 ng/ml and 100 ng/ml doses PNT1A, LNCaP and DU145 cells were assessed using dual parameter flow cytometry for the analysis of AcH3K9 and concurrent cell cycle changes. (A) Dual parameter scatterplots representing cellular levels of AcH3K9 (y-axis) against corresponding DNA content/cell cycle phase (x-axis). These plots show a differential distribution of AcH3K9 across the cell cycle which is intensified following TSA treatment and demonstrated the presence of a subpopulation of cells within the G2/M cell population in DU145, and to a lesser extent in LNCaP cells, that highly express AcH3K9. (B) Graphs showing MCF values generated from the dot plots in (A) for each TSA treatment group. These show variations in the levels of AcH3K9 within each cell cycle phase (G0/G1, S phase and G2/M) in addition to differential patterns of H3K9 acetylation between cell lines.
Fig. 5 TSA-induced chromatin changes in G1 enriched cell populations, as measured by quantitative digital texture analysis (A) Images show DNA distribution in red (PI) and AcH3K9 in green (FITC conjugated antibody) in G0/
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